NEXM NexMed Provides Update on Anti-Fungal ProductNexMed IncNEXM | 10/14/2009 8:45:00 AMCompany to Appeal Nasdaq Delisting Decision EAST WINDSOR, N.J.,
Oct 14, 2009 (BUSINESS WIRE) -- NexMed, Inc. (Nasdaq: NEXM), a developer of products based on the NexACT(R) technology, today announced that it has completed its post hoc analysis of NM100060, the Company's topically-applied treatment for ...